Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmelo Gurnari

Showing results (1-10 of 204) with videos related to

Pageof 21
Sort By:
British Journal of Haematology|October 25, 2021
'We cannot paint them all with the same brush': the need for a better definition of patients with myelodysplastic syndromes for clinical trial designCarmelo Gurnari, Valeria Visconte
British Journal of Haematology|November 7, 2022
Digging into the HLA pockets: A new association with acute leukaemiasCarmelo Gurnari, Simona Pagliuca
British Journal of Haematology|November 14, 2024
Dissecting the genomic traits and clinical course of secondary myelodysplastic syndrome following aplastic anaemia: A milestoneCarmelo Gurnari, Valeria Visconte
NEJM Evidence|April 28, 2026
Clonal Hematopoiesis after Immune Suppression - Adaptive Remodeling without Evolution? Early Lessons from the RACE TrialSimona Pagliuca, Carmelo Gurnari
Leukemia Research|February 25, 2023
From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular driversCarmelo Gurnari, Valeria Visconte
Clinical Rheumatology|August 9, 2025
A cross-sectional survey on VEXAS syndrome: insights from a global expert panelSyed B Ali, Carmelo Gurnari
Current Research in Translational Medicine|June 25, 2025
Infections in VEXAS syndrome: a systematic review of the literatureSyed B Ali, Carmelo Gurnari
Clinical Rheumatology|September 30, 2024
Allogenic haematopoietic stem cell transplantation in VEXAS: A review of 33 patientsSyed B Ali, Carmelo Gurnari
Seminars in Hematology|May 1, 2022
Aplastic anemia: Quo vadis?Carmelo Gurnari, Jaroslaw P Maciejewski
Blood|March 3, 2021
How I manage acquired pure red cell aplasia in adultsCarmelo Gurnari, Jaroslaw P Maciejewski
Pageof 21

Showing results (1-10 of 204) with videos related to

Sort By:
Pageof 21
British Journal of Haematology|October 25, 2021
'We cannot paint them all with the same brush': the need for a better definition of patients with myelodysplastic syndromes for clinical trial designCarmelo Gurnari, Valeria Visconte
British Journal of Haematology|November 7, 2022
Digging into the HLA pockets: A new association with acute leukaemiasCarmelo Gurnari, Simona Pagliuca
British Journal of Haematology|November 14, 2024
Dissecting the genomic traits and clinical course of secondary myelodysplastic syndrome following aplastic anaemia: A milestoneCarmelo Gurnari, Valeria Visconte
NEJM Evidence|April 28, 2026
Clonal Hematopoiesis after Immune Suppression - Adaptive Remodeling without Evolution? Early Lessons from the RACE TrialSimona Pagliuca, Carmelo Gurnari
Leukemia Research|February 25, 2023
From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular driversCarmelo Gurnari, Valeria Visconte
Clinical Rheumatology|August 9, 2025
A cross-sectional survey on VEXAS syndrome: insights from a global expert panelSyed B Ali, Carmelo Gurnari
Current Research in Translational Medicine|June 25, 2025
Infections in VEXAS syndrome: a systematic review of the literatureSyed B Ali, Carmelo Gurnari
Clinical Rheumatology|September 30, 2024
Allogenic haematopoietic stem cell transplantation in VEXAS: A review of 33 patientsSyed B Ali, Carmelo Gurnari
Seminars in Hematology|May 1, 2022
Aplastic anemia: Quo vadis?Carmelo Gurnari, Jaroslaw P Maciejewski
Blood|March 3, 2021
How I manage acquired pure red cell aplasia in adultsCarmelo Gurnari, Jaroslaw P Maciejewski
Pageof 21